Phlexglobal reveals PhlexEview v3
Phlexglobal
has announced the imminent launch of PhlexEview version 3, the third generation of its electronic Trial Master File (eTMF) solution.
PhlexEview 3 features an enhanced client-interface platform, system integration and the option of a “software as a service” model in response to Phlexglobal’s client requests and regulatory recommendations. It also features, as its standard TMF structure, the new DIA TMF Reference Model version 1.1, which was launched on February 9, 2011.
Phlexglobal’s eTMF solution, PhlexEview 3, is a quality-controlled, end-to-end process enabling electronic searching and viewing of centralized TMF documentation from sponsors, subsidiaries, CROs and field-based personnel from anywhere in the world at any time. Whether clients submit paper documents or upload electronic documents, use of PhlexEview 3 will ensure a regulatory compliant eTMF system can be presented to regulators and auditors.
Additions to PhlexEview 3 include new data import and export facilities, improved site architecture, and web services connectors to allow for seamless integration of defined documents with systems such as SharePoint and Documentum. This integration allows for centralized eTMFs without overloading enterprise-wide document management systems.
Other enhancements include features that support clinical trial management such as document comparison options and multiple quality control workflows. An expanded reporting module will be included for the first scheduled client implementations at the end of March 2011. These reports will allow for improved vendor and team oversight.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
